Velasof - Buy Generic Epclusa online 3$ per pill cost in India

A long search for an effective drug for the treatment of viral hepatitis C led to the invention of the antiviral drug Epclusa, Velasof is a combination of Velpatasvir and Sofosbuvir. The drug is available in tablet form, and its effectiveness has been clinically proven during long-term experiments. The country manufacturer of the means is Germany.

Composition and release form

Generic Epclusa drug is available in the form of tablets containing a combination of active antiviral components. The active components of the drug are sofosbuvir at a dosage of 400 mg and velpatasvir in an amount of 100 mg. The active ingredient velpatasvir is an inhibitor of the hepatitis C virus, and the contained sofosbuvir is an NS5B polymerase inhibitor of the hepatitis C pathogen.

Indications and therapeutic effect

Thanks to the combination of sofosbuvir and velpatasvir, this medicine successfully inhibits RNA polymerase of hepatitis C pathogens (inhibits reproduction).

Medicinal medication Epclusa showed high efficacy and is prescribed to patients suffering from viral hepatitis C, provoked by any of the genotypes of the pathogen. In addition, the drug based on sofosbuvir and velpatasvir is recommended for patients suffering from chronic viral hepatitis C, complicated by compensated and decompensated form of cirrhosis.